Special Procedural Measures in Intellectual Property Cases: Core Principles and Issues
Teka Komisji Prawniczej PAN Oddział w Lublinie · 30.06.2026 · 19 (1) · 531-547
DOI: 10.32084/tkp.10720 ↗Kurz gefasst
Fachartikel in der Zeitschrift Teka Komisji Prawniczej PAN Oddział w Lublinie, online erschienen am 30.06.2026. Verfasst von Wojciech Włodarczyk.
Abstract (Originalsprache)
This article examines the legal nature, structure, and function of special procedural measures in intellectual property cases under the Polish Code of Civil Procedure. These measures – preservation of evidence, disclosure or production of evidence, and requests for information – constitute an autonomous procedural framework shaped by the holistic character of IP law and by the principle of relative autonomy. The study clarifies the statutory concept of an ‘IP case’ and its significance for determining the scope of these measures. It argues that they are forms of judicial protection, not subjective rights, and that their application depends on procedural and substantive grounds provided for the Code while remaining constrained by proportionality and the need to balance fundamental rights. The analysis highlights interpretative challenges and stresses the importance of systemic and purposive reasoning, especially in the context of EU law.
Zitieren
APA
Włodarczyk, W. (2026). Special Procedural Measures in Intellectual Property Cases: Core Principles and Issues. Teka Komisji Prawniczej PAN Oddział w Lublinie, 19(1), 531-547. https://doi.org/10.32084/tkp.10720
Vancouver
Włodarczyk W. Special Procedural Measures in Intellectual Property Cases: Core Principles and Issues. Teka Komisji Prawniczej PAN Oddział w Lublinie. 2026;19(1):531-547. doi:10.32084/tkp.10720
BibTeX
@article{Wodarczyk2026,
author = {Włodarczyk, Wojciech},
title = {Special Procedural Measures in Intellectual Property Cases: Core Principles and Issues},
journal = {Teka Komisji Prawniczej PAN Oddział w Lublinie},
year = {2026},
volume = {19},
number = {1},
pages = {531--547},
doi = {10.32084/tkp.10720}
}
EUVIMED